O hipocampo dorsal (HD) é uma estrutura do sistema límbico que está envolvida em processos emocionais, de memória e aprendizado. Alem disso, o HD também exerce influência sobre a atividade autonômica. Durante situações aversivas pode se observar tanto respostas autonômicas (aumento da pressão arterial, frequência cardíaca e queda da temperatura cutânea) quanto comportamentais. O HD está envolvido com diversas alterações associadas a reações defensivas e apresenta conexões com diversas estruturas que modulam essas respostas, fazendo parte de uma via responsável por modular as respostas durante situações aversivas. São observadas aumentos nas respostas autonômicas durante o estresse por restrição (ER). Durante a atividade do HD está aumentada. Além disso, é possível observar aumento dos níveis de glutamato no HD. A ativação de receptores glutamatérgicos do tipo NMDA no sistema nervoso central aumenta a síntese de óxido nítrico (NO) por ativação da isoforma neuronial da óxido nítrico sintase (nNOS). Além disso, esta interação, NMDA/NO, no HD parece ser importante nas reações defensivas. Portanto, no presente estudo nós observamos que a administração de glutamato no HD promove aumentos do sistema cardiovascular, similares a aqueles observados durante situações de estresse. Estas respostas cardiovasculares são associadas com um aumento da atividade simpática. Além disso, os efeitos do glutamato foram inibidos pela administração do AP7, um antagonista NMDA, do N?-Propyl-L-Arginine, um inibidor da nNOS ou do Carboxy-PTIO(S)-3-carboxy-4- hydroxyphenylglicine, um sequestrador de NO. Finalmente, a administração destas drogas foi capaz de reduzir as respostas autonômicas causadas pelo ER. Portanto, nossos achados mostram que o sistema glutamatérgico presente no HD esta envolvido com a modulação autonômica através de receptores do tipo NMDA e a ativação de nNOS. Além disso, esta via NMDA/NO está envolvida na modulação autonômica durante situações de estresse. / The dorsal hippocampus (DH) is a structure of limbic system that is involved in emotional, leaning and memories process. Moreover, the DH also exerts influence on autonomic activity. During aversive situations it is possible observes autonomic responses (increase in blood pressure, heart rate and decrease in cutaneous temperature) associated to defensive behavioral. The DH is involved with alterations associated to defensive reactions and presents connections with several structures which modulate that responses, making part of a pathway involved with behavior and autonomic responses associated with aversive situations. Increase of autonomics responses are observed during restraint stress (RS). During RS the DH activity is increased. Moreover, it is possible observe increases in glutamate levels in DH. In central nervous system the activation of NMDA glutamatergic receptors increases the nitric oxide (NO) synthesis by activate the neuronal isoform of nitric oxide syntase (nNOS). Moreover, this interaction, NMDA/ NO, in the DH appears to important in the defensive reactions. Therefore, in the present work we observed that administration of glutamate in the DH promotes increases of cardiovascular system, similar those observed during stress situation. These cardiovascular responses were associate with an increase of sympathetic activity. Also, the glutamate effects were inhibited by administration of AP7, a NMDA antagonist, N?-Propyl-L-Arginine, a nNOS inhibitor, or Carboxy-PTIO(S)-3- carboxy-4-hydroxyphenylglicine, a NO scavenger. Finally, the administration of these drugs were able to reduces the autonomic responses evoked by RS. Therefore, our findings showed that glutamatergic system present in DH are involved with autonomic modulation through NMDA receptors and nNOS activation. Moreover, this NMDA/ NO is involved with autonomic modulation during stress situation.

O nosso grupo tem investigado os efeitos da Clorfeniramina (CPA), antagonista H1, e da L-histidina (LH), uma droga precursora da síntese de histamina, sobre a ansiedade e a memória emocional. Diante disso, os objetivos desse estudo foram investigar os efeitos LH administrada i.p. e da CPA microinjetada no hipocampo dorsal sobre a ansiedade e a memória emocional de camundongos submetidos ao labirinto em cruz elevado (LCE). O experimento foi realizado em dois dias consecutivos. No primeiro dia (T1) 71 camundongos machos da cepa Suíço-Albino pesando 25-35g foram pré-tratados i.p. com salina (SAL) ou LH (500mg/Kg). Após duas horas, os sujeitos receberam microinjeção de SAL ou CPA (0,016nmol; 0,052nmol; 0,16nmol/0,1l) no hipocampo dorsal. Após cinco minutos, os animais foram expostos ao LCE por cinco minutos. Vinte quatro horas depois, o mesmo protocolo experimental foi adotado na reexposição (T2). Os animais foram distribuídos aleatoriamente em 8 grupos de acordo com o tratamento farmacológico: SAL/SAL (n=9), SAL/CPA1 (n=9), SAL/CPA2 (n=10), SAL/CPA3 (n=8), LH/SAL (n=10), LH/CPA1 (n=8), LH/CPA2 (n=8) e LH/CPA3 (n=9). As três doses de CPA microinjetadas no hipocampo dorsal não alteraram a porcentagem de tempo gasto nos braços abertos (%TBA) na exposição ao LCE: T1 SAL/CPA1 (46,13±4,45); SAL/CPA2 (47,59±4,89); SAL/CPA3 (44,30±6,65) quando comparados com o grupo controle SAL/SAL (35,84±2,77) e não alteraram o número de entradas nos braços fechados (EBF) SAL/CPA1 (8,56±1,06); SAL/CPA2 (9,70±1,10); SAL/CPA3 (9,38±1,25) - quando comparados com o grupo controle SAL/SAL (10,56±1,11). A administração i.p. de LH aumentou a %TBA em T1 para o grupo LH/SAL (59,79±4,71), quando comparado ao grupo controle SAL/SAL (35,84±2,77), mas não alterou o EBF: LH/SAL (9,20±1,78) e SAL/SAL (10,56±1,11). Os animais do grupo LH/CPA3 diminuíram %TBA (32,25±4,81) em T1 quando comparados com o grupo LH/SAL (59,79±4,71). Os animais do grupo SAL/CPA1 não apresentaram diminuição da %TBA em T2 (T1: 46,13±4,45; T2: 39,38±6,53). O mesmo foi observado para os sujeitos dos grupos LH/CPA2 (T1: 50,10±3,99; T2: 40,97±8,22) e LH/CPA3 (T1: 32,25±4,81; T2: 32,16±6,93). Nós concluímos que: a CPA microinjetada no hipocampo dorsal de camundongos não apresenta efeito sobre a ansiedade; a administração intraperitoneal de LH apresenta efeito ansiolítico em camundongos expostos ao LCE e que esse efeito é revertido pela maior dose de CPA (0,16nmol/0,1l); são necessárias maiores doses de CPA para que haja prejuízo na memória emocional de camundongos reexpostos ao LCE quando os níveis de histamina no hipocampo dorsal estão elevados. / Our group has been investigating the effects of Chlorpheniramine (CPA), a histaminergic H1 antagonist, and of L-Histidine (LH), a histamine precursor, on anxiety-related behaviors and emotional memory. Thus the aim of this study was to investigate the effects of LH i.p. injections and of dorsal intra-hippocampal microinjections of Chlorpheniramine (CPA) on anxiety-related behaviors and emotional memory in male mice using elevated plus-maze (EPM). The experiment was performed in two days. On the first day (T1) 71 male Swiss Albino mice of body weight 25- 35g were pre-treated with saline (SAL) i.p. or LH (500mg/Kg) i.p. After two hours they were treated with dorsal intra-hippocampal microinjections of SAL or CPA (0.016nmol; 0.052nmol; 0.16nmol/0,1l). Five minutes after intra-hippocampal microinjections the animals were exposed to EPM for 5 minutes. Twenty four hours later the same protocol was repeated (T2). The animals were randomly assigned to 8 groups based on drug treatment: SAL/SAL (n=9), SAL/CPA1 (n=9), SAL/CPA2 (n=10), SAL/CPA3 (n=8), LH/SAL (n=10), LH/CPA1 (n=8), LH/CPA2 (n=8) and LH/CPA3 (n=9). All three doses of intra-hippocampal microinjections of CPA did not change the percentage of time spent in the open-arms (%OAT) on T1 SAL/CPA1 (46.13±4.45); SAL/CPA2 (47.59±4.89); SAL/CPA3 (44.30±6.65) when compared to control group SAL/SAL (35.84±2.77) and did not change the enclosed arm entries (EAE) SAL/CPA1 (8.56±1.06); SAL/CPA2 (9.70±1.10); SAL/CPA3 (9.38±1.25) when compared to control group SAL/SAL (10.56±1.11). Intraperitoneal injections of LH increased %OAT on T1 on LH/SAL group (59.79±4.71), when compared to control group SAL/SAL (35.84±2.77), but not EAE LH/SAL (9.20±1.78) and SAL/SAL (10.56±1.11). Animals treated with LH and CPA3 (LH/CPA3) decreased %OAT (32.25±4.81) on T1 when compared to LH/SAL (59.79±4.71) group. SAL/CPA1 animals did not decreased %OAT on T2 (T1: 46.13±4.45; T2: 39.38±6.53). The same happened to LH/CPA2 (T1: 50.10±3.99; T2: 40.97±8.22) and LH/CPA3 (T1: 32.25±4.81; T2: 32.16±6.93) groups. Thus, we conclude that: dorsal intra-hippocampal microinjection of Chlorpheniramine has no effect on anxiety-related behaviors in male mice; intraperitoneal injection of L-Histidine has an anxiolytic-like effect in male mice exposed to elevated plus-maze, that is reversed by the higher dose of Chlorpheniramine (0.16nmol/0,1l); higher doses of CPA are necessary to impair emotional memory when the levels of hippocampal histamine are elevated.

O nosso grupo tem investigado os efeitos da Clorfeniramina (CPA), antagonista H1, e da L-histidina (LH), uma droga precursora da síntese de histamina, sobre a ansiedade e a memória emocional. Diante disso, os objetivos desse estudo foram investigar os efeitos LH administrada i.p. e da CPA microinjetada no hipocampo dorsal sobre a ansiedade e a memória emocional de camundongos submetidos ao labirinto em cruz elevado (LCE). O experimento foi realizado em dois dias consecutivos. No primeiro dia (T1) 71 camundongos machos da cepa Suíço-Albino pesando 25-35g foram pré-tratados i.p. com salina (SAL) ou LH (500mg/Kg). Após duas horas, os sujeitos receberam microinjeção de SAL ou CPA (0,016nmol; 0,052nmol; 0,16nmol/0,1l) no hipocampo dorsal. Após cinco minutos, os animais foram expostos ao LCE por cinco minutos. Vinte quatro horas depois, o mesmo protocolo experimental foi adotado na reexposição (T2). Os animais foram distribuídos aleatoriamente em 8 grupos de acordo com o tratamento farmacológico: SAL/SAL (n=9), SAL/CPA1 (n=9), SAL/CPA2 (n=10), SAL/CPA3 (n=8), LH/SAL (n=10), LH/CPA1 (n=8), LH/CPA2 (n=8) e LH/CPA3 (n=9). As três doses de CPA microinjetadas no hipocampo dorsal não alteraram a porcentagem de tempo gasto nos braços abertos (%TBA) na exposição ao LCE: T1 SAL/CPA1 (46,13±4,45); SAL/CPA2 (47,59±4,89); SAL/CPA3 (44,30±6,65) quando comparados com o grupo controle SAL/SAL (35,84±2,77) e não alteraram o número de entradas nos braços fechados (EBF) SAL/CPA1 (8,56±1,06); SAL/CPA2 (9,70±1,10); SAL/CPA3 (9,38±1,25) - quando comparados com o grupo controle SAL/SAL (10,56±1,11). A administração i.p. de LH aumentou a %TBA em T1 para o grupo LH/SAL (59,79±4,71), quando comparado ao grupo controle SAL/SAL (35,84±2,77), mas não alterou o EBF: LH/SAL (9,20±1,78) e SAL/SAL (10,56±1,11). Os animais do grupo LH/CPA3 diminuíram %TBA (32,25±4,81) em T1 quando comparados com o grupo LH/SAL (59,79±4,71). Os animais do grupo SAL/CPA1 não apresentaram diminuição da %TBA em T2 (T1: 46,13±4,45; T2: 39,38±6,53). O mesmo foi observado para os sujeitos dos grupos LH/CPA2 (T1: 50,10±3,99; T2: 40,97±8,22) e LH/CPA3 (T1: 32,25±4,81; T2: 32,16±6,93). Nós concluímos que: a CPA microinjetada no hipocampo dorsal de camundongos não apresenta efeito sobre a ansiedade; a administração intraperitoneal de LH apresenta efeito ansiolítico em camundongos expostos ao LCE e que esse efeito é revertido pela maior dose de CPA (0,16nmol/0,1l); são necessárias maiores doses de CPA para que haja prejuízo na memória emocional de camundongos reexpostos ao LCE quando os níveis de histamina no hipocampo dorsal estão elevados. / Our group has been investigating the effects of Chlorpheniramine (CPA), a histaminergic H1 antagonist, and of L-Histidine (LH), a histamine precursor, on anxiety-related behaviors and emotional memory. Thus the aim of this study was to investigate the effects of LH i.p. injections and of dorsal intra-hippocampal microinjections of Chlorpheniramine (CPA) on anxiety-related behaviors and emotional memory in male mice using elevated plus-maze (EPM). The experiment was performed in two days. On the first day (T1) 71 male Swiss Albino mice of body weight 25- 35g were pre-treated with saline (SAL) i.p. or LH (500mg/Kg) i.p. After two hours they were treated with dorsal intra-hippocampal microinjections of SAL or CPA (0.016nmol; 0.052nmol; 0.16nmol/0,1l). Five minutes after intra-hippocampal microinjections the animals were exposed to EPM for 5 minutes. Twenty four hours later the same protocol was repeated (T2). The animals were randomly assigned to 8 groups based on drug treatment: SAL/SAL (n=9), SAL/CPA1 (n=9), SAL/CPA2 (n=10), SAL/CPA3 (n=8), LH/SAL (n=10), LH/CPA1 (n=8), LH/CPA2 (n=8) and LH/CPA3 (n=9). All three doses of intra-hippocampal microinjections of CPA did not change the percentage of time spent in the open-arms (%OAT) on T1 SAL/CPA1 (46.13±4.45); SAL/CPA2 (47.59±4.89); SAL/CPA3 (44.30±6.65) when compared to control group SAL/SAL (35.84±2.77) and did not change the enclosed arm entries (EAE) SAL/CPA1 (8.56±1.06); SAL/CPA2 (9.70±1.10); SAL/CPA3 (9.38±1.25) when compared to control group SAL/SAL (10.56±1.11). Intraperitoneal injections of LH increased %OAT on T1 on LH/SAL group (59.79±4.71), when compared to control group SAL/SAL (35.84±2.77), but not EAE LH/SAL (9.20±1.78) and SAL/SAL (10.56±1.11). Animals treated with LH and CPA3 (LH/CPA3) decreased %OAT (32.25±4.81) on T1 when compared to LH/SAL (59.79±4.71) group. SAL/CPA1 animals did not decreased %OAT on T2 (T1: 46.13±4.45; T2: 39.38±6.53). The same happened to LH/CPA2 (T1: 50.10±3.99; T2: 40.97±8.22) and LH/CPA3 (T1: 32.25±4.81; T2: 32.16±6.93) groups. Thus, we conclude that: dorsal intra-hippocampal microinjection of Chlorpheniramine has no effect on anxiety-related behaviors in male mice; intraperitoneal injection of L-Histidine has an anxiolytic-like effect in male mice exposed to elevated plus-maze, that is reversed by the higher dose of Chlorpheniramine (0.16nmol/0,1l); higher doses of CPA are necessary to impair emotional memory when the levels of hippocampal histamine are elevated.

O hipocampo dorsal (HD) é uma estrutura do sistema límbico que está envolvida em processos emocionais, de memória e aprendizado. Alem disso, o HD também exerce influência sobre a atividade autonômica. Durante situações aversivas pode se observar tanto respostas autonômicas (aumento da pressão arterial, frequência cardíaca e queda da temperatura cutânea) quanto comportamentais. O HD está envolvido com diversas alterações associadas a reações defensivas e apresenta conexões com diversas estruturas que modulam essas respostas, fazendo parte de uma via responsável por modular as respostas durante situações aversivas. São observadas aumentos nas respostas autonômicas durante o estresse por restrição (ER). Durante a atividade do HD está aumentada. Além disso, é possível observar aumento dos níveis de glutamato no HD. A ativação de receptores glutamatérgicos do tipo NMDA no sistema nervoso central aumenta a síntese de óxido nítrico (NO) por ativação da isoforma neuronial da óxido nítrico sintase (nNOS). Além disso, esta interação, NMDA/NO, no HD parece ser importante nas reações defensivas. Portanto, no presente estudo nós observamos que a administração de glutamato no HD promove aumentos do sistema cardiovascular, similares a aqueles observados durante situações de estresse. Estas respostas cardiovasculares são associadas com um aumento da atividade simpática. Além disso, os efeitos do glutamato foram inibidos pela administração do AP7, um antagonista NMDA, do N?-Propyl-L-Arginine, um inibidor da nNOS ou do Carboxy-PTIO(S)-3-carboxy-4- hydroxyphenylglicine, um sequestrador de NO. Finalmente, a administração destas drogas foi capaz de reduzir as respostas autonômicas causadas pelo ER. Portanto, nossos achados mostram que o sistema glutamatérgico presente no HD esta envolvido com a modulação autonômica através de receptores do tipo NMDA e a ativação de nNOS. Além disso, esta via NMDA/NO está envolvida na modulação autonômica durante situações de estresse. / The dorsal hippocampus (DH) is a structure of limbic system that is involved in emotional, leaning and memories process. Moreover, the DH also exerts influence on autonomic activity. During aversive situations it is possible observes autonomic responses (increase in blood pressure, heart rate and decrease in cutaneous temperature) associated to defensive behavioral. The DH is involved with alterations associated to defensive reactions and presents connections with several structures which modulate that responses, making part of a pathway involved with behavior and autonomic responses associated with aversive situations. Increase of autonomics responses are observed during restraint stress (RS). During RS the DH activity is increased. Moreover, it is possible observe increases in glutamate levels in DH. In central nervous system the activation of NMDA glutamatergic receptors increases the nitric oxide (NO) synthesis by activate the neuronal isoform of nitric oxide syntase (nNOS). Moreover, this interaction, NMDA/ NO, in the DH appears to important in the defensive reactions. Therefore, in the present work we observed that administration of glutamate in the DH promotes increases of cardiovascular system, similar those observed during stress situation. These cardiovascular responses were associate with an increase of sympathetic activity. Also, the glutamate effects were inhibited by administration of AP7, a NMDA antagonist, N?-Propyl-L-Arginine, a nNOS inhibitor, or Carboxy-PTIO(S)-3- carboxy-4-hydroxyphenylglicine, a NO scavenger. Finally, the administration of these drugs were able to reduces the autonomic responses evoked by RS. Therefore, our findings showed that glutamatergic system present in DH are involved with autonomic modulation through NMDA receptors and nNOS activation. Moreover, this NMDA/ NO is involved with autonomic modulation during stress situation.

Ο σκοπός της παρούσας διδακτορικής διατριβής ήταν η μελέτη της έκφρασης των υπομονάδων του GABAΑ υποδοχέα σε τομές από τον διαφραγματικό και τον κροταφικό ιππόκαμπο αμέσως μετά την θανάτωση του ζώου και κατά την διάρκεια της ανάπτυξης των "in vitro" οξέων κυμάτων που έχουν παρατηρηθεί μόνο σε τομές του κροταφικού ιππόκαμπου. Επιπλέον, μελετήθηκε η ποσοτική και τοπογραφική κατανομή των Α1 υποδοχέων αδενοσίνης με την χρήση του ραδιενεργού ιχνηθέτη [3H]-CHA (αγωνιστής των Α1 υποδοχέων) στον κροταφικό και τον διαφραγματικό ιππόκαμπο αμέσως μετά την θανάτωση του επίμυος. Η μελέτη της κατανομής των Α1 υποδοχέων αδενοσίνης έδειξε ότι η δέσμευση της [3H]-CHA ήταν μικρότερη στον κροταφικό σε σύγκριση με τον διαφραγματικό ιππόκαμπο με την μεγαλύτερη διαφορά να εντοπίζεται στην CA1 περιοχή. Το παραπάνω αποτέλεσμα έρχεται σε συμφωνία με την υπόθεση, ότι οι συνάψεις του κροταφικού ιππόκαμπου εμφανίζουν μεγαλύτερη πιθανότητα απελευθέρωσης γλουταμινικού οξέος σε σύγκριση με αυτές του διαφραγματικού ιππόκαμπου, καθώς οι Α1 υποδοχέων αδενοσίνης εντοπίζονται στην CA1 περιοχή κυρίως προσυναπτικά όπου ελέγχουν την απελευθέρωση γλουταμινικού οξέος. Στη συνέχεια της παρούσας μελέτης δείξαμε ότι η έκφραση του mRNA και των πρωτεϊνών για τις κυριότερες υπομονάδες του GABAA υποδοχέα είναι διαφορετική μεταξύ του διαφραγματικού και του κροταφικού ιπποκάμπου. Ειδικά, στην CA1 περιοχή του ιπποκάμπου η έκφραση των α1, β2 και γ2 υπομονάδων ήταν μικρότερη, ενώ αντίθετα η έκφραση των α2 και β1 υπομονάδων ήταν μεγαλύτερη στον κροταφικό ιπποκάμπο σε σύγκριση με τον διαφραγματικό ιππόκαμπο. Σύμφωνα με προηγούμενες μελέτες που αφορούν την συνέκφραση των υπομονάδων στο σύμπλοκο του GABAA υποδοχέα τα αποτελέσματα μας υποδηλώνουν ότι ο α1β2 υποτύπος του GABAA υποδοχέα επικρατεί στον διαφραγματικό ιππόκαμπο, ενώ ο α2β1 υπότυπος κυριαρχεί στον κροταφικό ιππόκαμπο. Η διαφορετική κατανομή των υποτύπων στους δυο πόλους του ιπποκάμπου που είναι εντονότερη στην CA1 περιοχή, μπορεί να επηρεάζει τις ιδιότητες του διαύλου (αγωγιμότητα, πλάτος και διάρκεια των IPSCs), δείχνοντας ότι οι υπότυποι του GABAA υποδοχέα που εντοπίζονται στον κροταφικό ιππόκαμπο έχουν μικρότερη ανασταλτική αποτελεσματικότητα, η οποία συμφωνεί με την μικρότερη GABAA-προερχόμενη αναστολή που έχει δειχθεί στην CA1 περιοχή του κροταφικού ιππόκαμπου. Επιπλέον θα μπορούσε να εξηγήσει την μεγαλύτερη επιρρέπεια του κροταφικού ιππόκαμπου στην επιληψία. Η χαμηλότερη έκφραση του mRNA για τις α4, β3 και δ υπομονάδες του GABAA υποδοχέα στην περιοχή της οδοντωτής έλικας του κροταφικού ιπποκάμπο υποδεικνύει ότι η έκφραση του α4β3δ υποτύπου είναι μικρότερη στον κροταφικό σε σύγκριση με τον διαφραγματικό ιππόκαμπο. Καθώς έχει δειχθεί ότι ο α4β3δ υπότυπος παίζει σημαντικό ρόλο στην τονική αναστολή στα κοκκιώδη κύτταρα της οδοντωτής έλικας, τα παραπάνω αποτέλεσμα μας πιθανώς σημαίνει ότι η τονική αναστολή είναι διαφορετική στους δυο πόλους του ιππόκαμπου. Η αύξηση της έκφρασης του mRNA της α5 υπομονάδας στην CA1 περιοχή του κροταφικού ιπποκάμπου μπορεί να επηρεάζει την ικανότητα για συναπτική βραχυ- και μακρο-χρόνια πλαστικότητα η οποία έχει βρεθεί να είναι διαφορετική μεταξύ του κροταφικού και του διαφραγματικού ιπποκάμπου καθώς έχει δειχθεί ότι οι α5-υπότυποι παίζουν ρόλο σε διαδικασίες μνήμης και μάθησης. Επίσης, οι α5-υπότυποι του GABAA υποδοχέα στην CA1 περιοχή του ιππόκαμπου συμμετέχουν στην τονική αναστολή. Τα υψηλότερα επίπεδα στην έκφραση του mRNA για την α5 υπομονάδα στον κροταφικό ιππόκαμπο σε σύγκριση με τον διαφραγματικό ιππόκαμπο πιθανώς υποδεικνύουν ότι η τονική αναστολή είναι διαφορετική στην CA1 περιοχή των δυο πόλων του ιππόκαμπου. Στο δεύτερο μέρος της παρούσας διατριβής μελετήσαμε την πιθανή συσχέτιση του GABAεργικού συστήματος με την οργάνωση των "in vitro" οξέων κυμάτων η οποία έχει παρατηρηθεί, σε κανονικές "in vitro" συνθήκες, μόνο σε τομές του κροταφικού ιππόκαμπου. Για το λόγο αυτό πραγματοποιήσαμε αναλυτική μελέτη της έκφρασης του mRNA των υπομονάδων (α1, α2, α5, β1, β2, β3, γ2) του GABAΑ υποδοχέα σε διάφορα χρονικά διαστήματα κατά την κανονική "in vitro" διατήρηση των τομών (15min, 1, 3, 5 και 8h). Αρχικά μελετήσαμε την έκφραση των πρώιμων γονιδίων (c-fos, zif-268), που είναι δείκτες της νευρωνικής ενεργότητας, μετά από 5 ώρες κανονικής "in vitro" διατήρησης των τομών με σκοπό τη πιθανή συχέτιση της έκφρασης τους με την οργάνωση των "in vitro" οξέων κυμάτων. Τα αποτελέσματα μας έδειξαν και στους δυο πόλους του ιπποκάμπου παρόμοια αύξηση της έκφρασης του mRNA τόσο για το c-fos όσο και για zif-268 γεγονός που υποδηλώνει ότι γονιδιακή ενεργότητα είναι παρόμοια και όσο αφορά τα συγκεκριμένα πρώιμα γονίδια ανεξάρτητη της ανάπτυξης των "in vitro" οξέων κυμάτων. Στην CA1 περιοχή του κροταφικού ιππόκαμπου παρατηρήθηκε σημαντική αύξηση της έκφρασης του mRNA των α1, β2 και γ2 υπομονάδων του GABAΑ υποδοχέα η οποία ξεκινάει την 1η ώρα, δηλαδή πριν την οργανωμένη εμφάνιση της αυθόρμητης δραστηριότητας, γίνεται μέγιστη στις 4 ώρες παραμονής των τομών σε Τεχνητό Εγκεφαλονωτιαίο Υγρό (ΤΕΝΥ) και συμβαδίζει χρονικά με την οργάνωση των "in vitro" οξέων κυμάτων. Δεν παρατηρήθηκαν σημαντικές αλλαγές σε τομές που προέρχονται από τον διαφραγματικό ιππόκαμπο. Έχει δειχθεί ότι οι α1-υπότυποι παίζουν σημαντικό ρόλο στην ανασταλτική ικανότητα του υποδοχέα. Επίσης η παρουσία της β2 υπομονάδας στον δίαυλο χαρακτηρίζει μεγαλύτερα σε πλάτος και διάρκεια ανασταλτικά ρεύματα συγκρινόμενη με τις β1 υπομονάδες. Φαίνεται λοιπόν ότι ο υπότυπος α1β2γ2, του οποίου η έκφραση αυξάνει πριν την έναρξη της οργανωμένης ρυθμικής δραστηριότητας, λόγω της συγκρότησης του από τις συγκεκριμένες υπομονάδες, έχει μεγάλη ανασταλτική αποτελεσματικότητα η οποία μπορεί να συμμετέχει στην ανάπτυξη των "in vitro" οξέων κυμάτων. Η δέσμευση της [3H]–muscimol αυξάνει σε τομές που προέρχονται μόνο από τον κροταφικό ιππόκαμπο και έχουν παραμείνει σε κανονικές "in vitro" συνθήκες για 8 ώρες σε σύγκριση με αντίστοιχες τομές που προέρχονται αμέσως μετά την θανάτωση του ζώου. Καμία αλλαγή δεν παρατηρήθηκε στην δέσμευση της [3H]–muscimol σε τομές που προέρχονται από τον διαφραγματικό ιππόκαμπο. Η αύξηση της δέσμευσης της [3H]–muscimol μόνο στις τομές που προέρχονται από τον κροταφικό ιππόκαμπο είναι σε συμφωνία με την αύξηση της έκφρασης του α1β2γ2-υποτύπου καθώς έχει δειχθεί ότι η θέση δέσμευσης της muscimol στο δίαυλο του GABAA υποδοχέα είναι μεταξύ των α1 και β2 υπομονάδων. Συμπερασματικά, η εκλεκτική αύξηση της έκφρασης του α1β2γ2-υπότυπου μόνο στην CA1 περιοχή του κροταφικού δηλώνει μεγαλύτερη ανασταλτική αποτελεσματικότητα των GABAA υποδοχέων, δεδομένου ότι ο α1β2γ2-υπότυπος προκαλεί μεγαλύτερα ανασταλτικά μετασυναπτικά ρεύματα. Το παραπάνω μπορεί να σχετίζεται με την "in vitro" εμφάνιση των οξέων κυμάτων καθώς η αυθόρμητη δραστηριότητα προέρχεται από GABAA-επαγόμενες υπερπολώσεις των πυραμιδικών κυττάρων, ενώ και η αύξηση στην έκφραση του α1β2γ2-υποτύπου συμπίπτει χρονικά με την εμφάνιση των "in vitro" οξέων κυμάτων. / The hippocampus in the rat appears grossly as an elongated structure with its long axis bending in a C-shaped manner from the septal nuclei rostrodorsally to the incipient temporal lobe caudoventrally. The long axis of the hippocampal formation is referred as the dorsoventral axis. Although hippocampus has been traditionally thought as a homogeneous structure, several studies have been demonstrated differences at several organization levels (from the behavioural to the cellular) between its dorsal (DH) and ventral (VH) pole. In the present study, we examined whether the recently reported differences in the GABA-mediated somatic inhibition between the DH and VH could be related to variations in the GABAA receptors. We therefore studied the quantitative distribution, the kinetic parameters and the subunit composition of the GABAA receptors in the two parts of hippocampus. We also studied the A1 adenosine receptors in order to examine the involvement of the adenosinergic system in the glutamate release between the two hippocampal poles. The study of [3H]-CHA binding on A1 adenosine receptors by using "in vitro" quantitative autoradiography, revealed a weaker A1 receptor binding in VH compared to DH in all regions we examined. Taken into consideration that the A1 adenosine receptors are localized in the CA1 glutamatergic terminals, these results may to some extend explain our hypothesis that synapses in the VH have greater probability of glutamate release compared to those in the DH counterpart. Recent data have demonstrated a weaker somatic GABAergic inhibition in CA1 region of VH compared to DH. We therefore examined possible differences in the GABAA receptor subunit composition and receptor binding parameters between DH and VH by using "in situ" hybridization, western blotting and the specific binding of the GABAA receptor agonist [3H]-muscimol using quantitative autoradiography and saturation experiments. The experiments demonstrated that the VH compared to DH displayed: 1) lower levels of mRNA expression for α1, β2, γ2 but higher levels for α2 and β1 subunits in CA1, CA2 and CA3, with the differences being more pronounced in CA1 region. Western blot analysis confirmed the mRNA expression data, showing lower levels for α1, β2 and higher levels for α2 subunits’ protein. Only in the CA1 region the mRNA levels of α5 were higher, while those of α4 subunit were slightly lower; in dentate gyrus, the mRNA levels of α4, β3 and δ subunits were significantly lower in VH compared to DH presumably suggesting a lower expression of the α4/β3/δ receptor subtype; 2) lower levels of [3H]-muscimol binding in the VH, with the lowest value observed in CA1, apparently resulting from weaker affinity for GABA and not from a decreased receptor density, since the KD values were higher in VH, while the Bmax values were similar between DH and VH. In conclusion, the differences in the subunit mRNA and protein expression and the lower affinity of GABAA receptor observed predominantly in CA1 region of VH, suggest that the α1 subunit-containing GABAA receptors dominate in the DH, while the α2 subunit-containing receptors prevail in VH. This could underlie the lower GABAA mediated somatic inhibition observed in VH and, to some extent, explain: a) the higher liability of VH for epileptic activity and b) the differential involvement of DH and VH in cognitive and emotional processes. Recent electrophysiological experiments have been shown that slices from the VH of adult rats generate rhythmical activity during their maintenance in the recording chamber. This activity is fully organized during the first 3 hours of in vitro maintenance and resembles the in vivo recorded hippocampal "sharp waves", therefore called "in vitro sharp waves". The field manifestation of this spontaneous activity results from GABAA receptor-mediated hyperpolarizations in pyramidal cells. The aim of the second part of the present thesis focused on the possible relationship between the characteristics of GABAA receptors and the development of "in vitro sharp waves". Using the "in situ hybridisation" technique, we examined the mRNA expression of the alpha1/2/5,beta1/2/3 and gamma2 subunits of GABAA receptor and the binding of GABAA receptor agonist [3H]-muscimol in a time course including periods before and during the development of the "in vitro sharp waves". Six sets of transversely cut DH and VH slices were prepared: slices frozen immediately after killing the animal (naive slices), and slices maintained in vitro and frozen at different time points (15min, 1, 3, 5 and 8h) during the electrophysiological experiment. The results showed: A) Upregulation of alpha1, beta2 and gamma2 subunits mRNA in VH but not in DH slices at 1h of their maintenance, which became significant at 3h as compared to the respective naive slices; B) Increase in [3H]-muscimol binding only in VH slices, obtained at 8h compared to the respective naive ones. The upregulation of the α1β2γ2 GABAA receptor subtype (starting at 1h) in VH but not in DH presumably suggests an increase in GABAergic activity, which could be related with the appearance of "in vitro sharp waves" observed only in VH; C) Τhe similar mRNA expression of the early genes c-fos and zif-268 in the two hippocampal poles showing a comparable general gene activity in DH and VH. In conclusion, the α1β2γ2 subtype dominates in DH while the α2β2-subtype prevails in VH and this could be related to the weaker somatic inhibition observed in the CA1 region of VH, and also to the distinct involvement of DH and VH in cognitive and emotional processes. Moreover, the higher expression of the GABAA receptor subtype α4β4δ in the DG of DH compared to VH may imply a higher tonic inhibition in the former hippocampal pole. The upregulation of the α1β2γ2- subtype only in VH slices during their in vitro maintenance may reflect an increase in the impact of GABAA receptor-mediated transmission, which is required for the organization of "in vitro" sharp waves.

Vários estudos utilizando modelos animais têm demonstrado que estruturas límbicas como amídala (AMD), hipocampo dorsal (HD) e córtex pré-frontal medial (CPFm) participam na consolidação da memória associada às emoções. Considerando que a síntese de novas proteínas é necessária para o processo de consolidação de memórias, e que a combinação entre o uso de inibidores de síntese proteica e diferentes intensidades de estímulo incondicionado têm gerado respostas comportamentais distintas com relação à consolidação da memória emocional, o presente trabalho se propôs a investigar a hipótese de a consolidação da memória aversiva na AMD, no HD e no CPFm, associada a síntese proteica, ocorre de maneira diferenciada nessas três estruturas, de acordo com a intensidade do estímulo aversivo, bem como se a expressão de genes envolvidos na transmissão histaminérgica seria modificada ao longo das fases da memória emocional aversiva. O objetivo do presente estudo foi avaliar o papel da síntese proteica na AMD, HD e CPFm no processo de consolidação de uma memória aversiva baseada em condicionamento aversivo moderado ou intenso; investigar a expressão de genes ligados a transmissão histaminérgica na AMD, HD e CPFm após o condicionamento aversivo intenso. Para este fim dois experimentos foram realizados: No experimento 1 a anisomicina (ANI) foi microinjetada bilateralmente na AMD ou HD ou CPFm de camundongos antes de serem submetidos a tarefa de esquiva inibitória do tipo step-down utilizando duas intensidades de estímulo incondicionado: moderada ou intensa. No experimento 2, as variações da expressão dos genes da enzima HDC (histidina descarboxilase responsável pela síntese de histamina) e dos receptores H1, H2 e H3 foram analisadas em diferentes espaços temporais através da reação de polimerase em cadeia em tempo real. Os resultados do experimento 1 demonstram que microinjeção de ANI no CPFm prejudica a consolidação da memória de esquiva inibitória com estímulo incondicionado moderado ou intenso, porém quando administrada intra-AMD e intra-HD, a ANI só prejudica a consolidação da memória de esquiva inibitória com estímulo incondicionado intenso. No experimento 2 demonstra que durante a consolidação da memória aversiva intensa há diminuição nos níveis de expressão dos genes: HDC no HD, Hrh3 na AMD, Hrh1 e Hrh3 no CPFm. Já na fase de evocação, na AMD há aumento e diminuição na expressão dos genes HDC e Hrh3, respectivamente; no HD há aumento na expressão dos genes Hrh2 e Hrh3 e no CPFm há aumento na expressão do gene HDC e diminuição nos genes Hrh1 e Hrh3. Durante a reconsolidação há diminuição na expressão dos genes HDC e Hrh3 e aumento do gene Hrh1 na AMD. No DH há aumento com relação ao gene Hrh1, e no CPFm há aumento do gene HDC e diminuição na expressão dos genes Hrh1 e Hrh3. No presente estudo conclui-se que em situações com moderado grau de aversividade, a consolidação dessa experiência não dependerá de síntese proteica na AMD e no HD, mas sim no CPFml. No entanto, em situações com elevado grau de aversividade, a síntese proteica na AMD, HD e CPFm é essencial para a consolidação de tal experiência. Além disso, os genes HDC, Hrh1, Hrh2 e Hrh3 se expressam distintamente na AMD, HD e CPFm ao longo da escala temporal da consolidação, evocação e reconsolidação da formação de memórias de medo. / Several studies using animal models have shown that limbic structures like the amygdala (AMG), dorsal hippocampus (DH) and medial prefrontal cortex (mPFC) are involved in emotional memory consolidation. Whereas the synthesis of new proteins is necessary for memory consolidation process, and that opposite results related to the interaction of protein synthesis inhibitors and foot-shock intensity on memory consolidation have been reported, the present study aims to investigate the hypothesis of protein synthesis in AMG, the DH and mPFC associated with the consolidation of aversive memory occurs differently in these three structures, according to the intensity of the aversive stimulus and the expression of proteins involved in histaminergic transmission would be modified during the process of consolidation and emotional expression of aversive memory. The aim of this study was to evaluate the role of protein synthesis in AMG, DH and mPFC in consolidation of aversive memory based on moderate and intense conditioning; to investigate the expression of proteins related to histaminergic transmission in AMG, DH and mPFC after intense aversive conditioning. For this purpose two experiments were performed: in experiment 1 the anisomycin (ANI) was bilaterally microinjected into AMG or DH or mPFC of mice before being submitted the step-down inhibitory avoidance task using two unconditioned stimulus intensities: moderate or intense. In experiment 2, the variations in the gene expression of HDC enzyme (histidine decarboxylase - responsible for histamine synthesis) and the H1, H2 and H3 receptors were analyzed at different temporal spaces by real-time polymerase chain reaction (RT-PCR). The results of the first experiment demonstrate that microinjection of ANI in mPFC impairs the consolidation of inhibitory avoidance memory with moderate or intense unconditioned stimulus, however when administered intra-AMG and intra DH, ANI only impairs the consolidation of inhibitory avoidance memory under an intensive unconditioned stimulus. The experiment 2 demonstrates that during the consolidation of intense aversive memory there is a decrease of the genes expression levels: HDC in the dorsal hippocampus, Hrh3, Hrh1 in the amygdala, and Hrh3 in the medial prefrontal cortex. During retrieval the HDC and Hrh3 genes expression levels are increased and decreased, respectively in the AMG; the Hhr2 and Hrh3 genes expression levels are increased in the DH, and in the mPFC the HDC gene expression level is increased, and the Hrh1 and Hrh3 are decreased. During reconsolidation the amygdalas HDC and Hrh3 genes expression levels are decreased and the Hrh1 gene is increased. In the DH the Hrh1 gene levels are elevated and in the mPFC the HDC gene expression level is increased and the Hrh1 and Hrh3 are decreased. In the current study we conclude that under moderate aversiveness situations, the consolidation of this experience does not depend on protein synthesis in the AMG and in the DH, but in the mPFC. However, in situations with a high level of adversity, protein synthesis in this three structures are essential for the consolidation of such experience. In addition, the histaminergic genes are distinctly expressed in the AMG, DH and mPFC along the time scale of consolidation, retrieval and reconsolidation of the formation of fear memories.

Vários estudos mostram que o núcleo mediano da rafe (NMR) e o hipocampo dorsal (HD) estão envolvidos no medo condicionado Pavloviano. Além disso, mecanismos serotoninérgicos do NMR parecem participar da expressão da resposta de medo condicionado contextual. Entretanto, ainda não existe uma abordagem experimental que integre os mecanismos do circuito NMR-HD. Neste trabalho, o paradigma do medo condicionado foi utilizado para testar a influência dos mecanismos serotoninérgicos do circuito NMR-HD no medo condicionado contextual. As respostas de sobressalto e congelamento foram avaliadas após a administração de drogas serotoninérgicas intra-NMR e no HD, 6 h depois a sessões treino, nas quais os ratos eram condicionados com choques nas patas. A redução da transmissão serotoninérgica no NMR é devido a microinjeção do 8-hidroxi-2(di-n-propilamino)-tetralin (8-OH-DPAT), um agonista de receptores 5-HT1A, no NMR promoveu redução das respostas de congelamento, mas não alterou a resposta de sobressalto. Estes resultados são consistentes com a ideia de que mecanismos serotoninérgicos no NMR regulam as respostas de congelamento a um contexto aversivo. A diminuição pós-sináptica da serotonina nas áreas de projeção do NMR ocorre devido a ativação de autoreceptores 5-HT1A nesta estrutura. Com relação ao hipocampo, a microinjeção de cetanserina, um antagonista de receptores 5-HT2, não promoveu alteração nas respostas de congelamento e sobressalto potencializado pelo medo, porém a ativação de receptores 5-HT1A pela injeção de 8-OH-DPAT 6 h após o treino inibiu essas respostas. De acordo com esses resultados, um mecanismo inibitório deva se interpor entre os processos associados à chegada de informação aversiva e os associados à saída delas no HD. As projeções HD-amígdala e córtex pré-frontal medial podem constituir a porta de saída dos processos neurais subjacentes a expressão do medo condicionado contextual, conforme foi observado no experimento em que estudou a imunorreatividade destas estruturas á proteína Fos em ratos submetidos ao mesmo procedimento experimental de medo condicionado contextual / Several studies have shown that the median raphe nucleus (MRN) and dorsal hippocampus (DH) are involved in Pavlovian conditioned fear. Moreover, previous findings have also implicated serotonergic mechanisms of the MRN in the retrieval of contextual conditioned fear. However, studies that examine the integrated involvement of serotonergic mechanisms of the MRN-DH are lacking. This study, a fear conditioning paradigm was used to test whether the serotonergic projections from the MRN to DH can influence contextual fear conditioning. Startle and freezing responses were avaliated after administration of serotoninergics drugs into the MRN or DH, 6 h previously rats received footshocks in the training session. A reduction of 5-HT transmission in the MRN by local infusions of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) decreased freezing in response to the CS but did not reduce fear-potentiated startle. This pattern of results is consistent with the hypothesis that MRN serotonergic mechanisms selectively modulate the freezing response to the aversive context. As for the DH, a decrease in postsynaptic 5-HT receptor activity at projection areas has been proposed to be the main consequence of 5-HT1A receptor activation in the MRN. Infusions of the 5-HT2 receptor antagonist ketanserin into the DH had no effect, but activation of 5-HT1A receptors through intra-DH injections of 8-OH-DPAT inhibited both the freezing and fear-potentiated startle response to the CS. To reconcile these findings, an inhibitory mechanism may exist between the incoming DH 5-HT pathway from the MRN and the presynaptic 5-HT neurons that are part of the DH output to other structures. The DH-amygdala and medial prefrontal cortex projections could well be this output circuit modulating the expression of contextual fear conditioning as revealed by measurements of Fos immunoreactivity in these areas.

A dependência de drogas é um transtorno multifatorial complexo que se desenvolve em uma minoria de indivíduos que fazem uso dessas substâncias. Memórias associativas entre a droga e o contexto funcionam como gatilho para disparar comportamentos não adaptativos de busca e consumo, além de recaídas após períodos de abstinência. Subjacentes a essas mudanças comportamentais, existem modificações nas subunidades de receptores glutamatérgicos do tipo AMPA em estruturas envolvidas com memória (Hipocampo) e recompensa (Núcleo Accumbens). Por isso, estratégias que enfraqueçam a associação do contexto com a droga e que aprofundem o conhecimento dos circuitos envolvidos nesses comportamentos são de extrema relevância terapêutica. A memória quando evocada pode passar por dois processos pós-evocação: a extinção, em que uma nova memória é formada inibindo uma prévia associação, e a reconsolidação, em que a memória original entra em um estado lábil e suscetível a modificações, em que é possível enfraquecê-la através da inibição de sua reconsolidação. A reconsolidação da memória mostra-se uma estratégica mais eficaz e duradoura em relação à extinção, já que a memória original é modificada. Como modelo animal para o estudo da memória na dependência de drogas, o condicionamento de preferência por local (CPL) é bastante utilizado e sabe-se que é possível enfraquecer a preferência através do bloqueio da reconsolidação. Porém, são escassos os estudos que investigaram a existência da reconsolidação no modelo de sensibilização locomotora, que parece ocorrer, na maioria dos casos, em condição dependente do contexto de aquisição do comportamento, embora existam exemplos que demonstrem sua independência. As questões a serem respondidas neste trabalho são (a) se é possível reverter conjuntamente a preferência por local e a sensibilização locomotora à morfina (5 mg/kg) em ratos Wistar adultos machos, inibindo-se a síntese proteica com cicloheximida (CHX) i.p. logo após uma sessão de reativação contextual da memória no CPL, (b) se a reversão dos comportamentos reflete alterações (já descritas por outros autores) em GluA1, GluA1p (Ser845) e GluA2, no Hipocampo dorsal (HPCd) e no Núcleo Accumbens (NAc), e (c) se o mesmo tratamento em ambas estruturas reverte os dois parâmetros avaliados – comportamental e neuroquímico – de forma diferente ou igual. Nossos resultados mostraram ser possível reverter a preferência por local e a sensibilização locomotora por inibição sistêmica de síntese proteica, e que o condicionamento com exposição à morfina induz alterações nas subunidades analisadas de AMPA, conforme verificado no HPCd e NAc, embora a CHX não tenha produzido um efeito tão bem definido. Os animais que receberam infusões centrais no HPCd e NAc (central) não exibiram preferência por local, nem sensibilização. Em conjunto, nossos resultados mostraram, pela primeira vez em um mesmo desenho experimental, que é possível reverter diferentes aspectos da memória de recompensa (preferência e sensibilização) por meio do bloqueio da reconsolidação. / Drug addiction is a complex and multifactorial disorder that develops in a few people who use these substances. Associative memories between the drug and context of use act as a trigger for maladaptive behavior such as drug seeking and drug use, in addition to relapse after an extended period of withdrawal. Underlying these behavioral changes are modifications in glutamatergic reception (AMPA) in structures involved with memory (Hippocampus) and reward (Nucleus Accumbens). Therefore, strategies that weaken the drug and context association and deepen knowledge of circuits involved in these behaviors are extremely relevant therapeutically. When retrieved, a memory can undergo two distinct processes post-retrieval: extinction, in which a new memory inhibiting a previous association is generated, and reconsolidation, in which the original memory can enter a labile state and is susceptible to modifications, when it can be weakened by inhibition of its reconsolidation. Reconsolidation of memory has been shown to be a more effective and long lasting strategy in relation to extinction, since the original memory is modified. An animal model for studying drug addiction, conditioned place preference (CPP) is largely used and it is well known that it is possible to weaken preference by disrupting reconsolidation. However, there are few studies that investigate the existence of reconsolidation in a locomotor sensitization paradigm, which seems to occur in a condition dependent on context of acquisition, although some works report its independence. The questions answered in this work were (a) if it is possible to reverse both, context preference and locomotor sensitization to morphine (5mg/kg) by protein synthesis inhibition (CHX) after a contextual memory reactivation session in CPP, (b) if the disruption of behaviors reflects a reversal of changes of GluA1, GluA1p (Ser845) e GluA2 in dorsal Hippocampus (dHPC) and Nucleus Accumbens (NAc) and (c) if the same treatment in these structures differentially reverts the two parameters assessed. Our results indicate that it is possible to revert context preference and locomotor sensitization via systemic disruption of protein synthesis and that morphine conditioning induces changes in AMPA subunits in dHPC and NAc, although CHX did not have an evident effect on molecular reversal. Animals cannulated in dHPC and NAc core did not induce preference or sensitization. Taken together, our results demonstrated, for the first time, using the same experimental design that is possible to revert different aspects of reward memory (preference and sensitization) by disrupting the reconsolidation process.

Estudos com microinjeções de drogas vêm sendo realizados na tentativa de se compreender a participação da neurotransmissão serotonérgica do hipocampo na modulação de comportamentos defensivos relacionados à ansiedade. Nesse sentido, observou-se que a ativação dos receptores do tipo 5-HT1A do hipocampo dorsal (HD) promoveu efeito do tipo ansiogênico sobre a resposta de esquiva inibitória, sem alterar a resposta de fuga, em ratos submetidos ao labirinto em T elevado (LTE). Essa alteração seletiva na resposta de esquiva inibitória sustenta a hipótese da participação do hipocampo na fisiopatologia do transtorno de ansiedade generalizada, uma vez que, as respostas defensivas de esquiva inibitória e fuga, expressas no LTE, têm sido relacionadas respectivamente ao transtorno de ansiedade generalizada e ao transtorno do pânico. Além de receptores do tipo 5- HT1A, destaca-se no HD a presença de receptores do tipo 5-HT2C. Tem sido observado que a estimulação desses últimos em áreas límbicas associadas à ansiedade, como a amígdala, promove efeito do tipo ansiogênico em diferentes modelos animais de ansiedade. Porém, ainda é desconhecida a participação desses receptores presentes no HD sobre as resposta de esquiva inibitória e fuga, geradas no LTE. Assim, o presente estudo procurou avaliar a participação dos receptores serotonérgicos do tipo 5-HT2C na modulação de respostas defensivas relacionadas à ansiedade generalizada e ao transtorno do pânico. Os resultados mostram que injeções bilaterais intra-HD dos agonistas de receptores 5-HT2C MK-212 ou RO600175 prejudicaram a aquisição da resposta de esquiva inibitória, em ratos testados no LTE, indicando um efeito do tipo ansiolítico. Por outro lado, a administração do antagonista de receptores 5-HT2C SB-242084 promoveu efeito oposto sobre essa mesma resposta. Adicionalmente administração do agonista preferencial de receptores 5-HT2A DOI não foi capaz de promover efeito em nenhuma das doses utilizadas. Nenhum dos tratamentos empregados alterou a resposta de fuga no LTE. O efeito ansiolítico da ativação dos receptores 5-HT2C, bem como o efeito ansiogênico resultante do seu bloqueio, foram confirmados no teste do beber punido de Vogel. Em suma, nossos resultados sugerem que os receptores do tipo 5-HT2C do hipocampo dorsal estão envolvidos na modulação de comportamentos defensivos relacionados ao transtorno de ansiedade generalizada, mas não ao transtorno do pânico. / Studies using intracerebral microinfusion of drugs have been performed to unveil the role of the hippocampus serotonergic system in the modulation of anxiety-related defensive behaviors. For instance, it has been shown that activation of 5-HT1A receptors in the dorsal hippocampus (DH) facilitated inhibitory avoidance acquisition, suggesting an anxiogenic effect, without altering escape expression in rats tested in the elevated T-maze (ETM). This selective effect on inhibitory avoidance response is consistent with the notion that the hippocampus is critically involved in the pathophysiology of generalized anxiety disorder. Besides 5-HT1A receptors, expressive levels of 5-HT2C receptors are also reported in hippocampus. Compelling evidence from animal studies shows that facilitation of 5-HT2C receptor-mediated neurotransmission increases anxiety. In this study we evaluated the involvement the 5-HT2C receptors of the DH in the regulation of defensive behaviors that have been associated with generalized anxiety and panic. Male Wistar rats were tested in the ETM after intra-DH injection of the 5-HT2C receptor agonists MK-212, RO-600175, or the preferential 5-HT2A receptor agonist DOI, or the 5-HT2C receptor antagonist SB242084. For comparative reason, the effect of MK-212, RO-600175 and SB-242084 was also evaluated on another generalized anxiety-associated model, the Vogel conflict test. Our results showed that while intra-DH microinjection of both MK-212 and RO-600175 facilitated inhibitory avoidance acquisition, suggesting an anxiolytic effect, SB-242084 had the opposite effect. Injections of DOI did not affected performance in ETM. None of these drugs affected escape performance in the ETM. The anxiolytic-like effects of the 5-HT2C receptor agonists and anxiogenic-like effect of the SB-242084 were also observed in the Vogel conflict test. Our findings indicate that 5-HT2C receptors in DH are selectively involved in the regulation of defensive behaviors associated with generalized anxiety, but not panic.

Estudos com microinjeções de drogas vêm sendo realizados na tentativa de se compreender a participação da neurotransmissão serotonérgica do hipocampo na modulação de comportamentos defensivos relacionados à ansiedade. Nesse sentido, observou-se que a ativação dos receptores do tipo 5-HT1A do hipocampo dorsal (HD) promoveu efeito do tipo ansiogênico sobre a resposta de esquiva inibitória, sem alterar a resposta de fuga, em ratos submetidos ao labirinto em T elevado (LTE). Essa alteração seletiva na resposta de esquiva inibitória sustenta a hipótese da participação do hipocampo na fisiopatologia do transtorno de ansiedade generalizada, uma vez que, as respostas defensivas de esquiva inibitória e fuga, expressas no LTE, têm sido relacionadas respectivamente ao transtorno de ansiedade generalizada e ao transtorno do pânico. Além de receptores do tipo 5- HT1A, destaca-se no HD a presença de receptores do tipo 5-HT2C. Tem sido observado que a estimulação desses últimos em áreas límbicas associadas à ansiedade, como a amígdala, promove efeito do tipo ansiogênico em diferentes modelos animais de ansiedade. Porém, ainda é desconhecida a participação desses receptores presentes no HD sobre as resposta de esquiva inibitória e fuga, geradas no LTE. Assim, o presente estudo procurou avaliar a participação dos receptores serotonérgicos do tipo 5-HT2C na modulação de respostas defensivas relacionadas à ansiedade generalizada e ao transtorno do pânico. Os resultados mostram que injeções bilaterais intra-HD dos agonistas de receptores 5-HT2C MK-212 ou RO600175 prejudicaram a aquisição da resposta de esquiva inibitória, em ratos testados no LTE, indicando um efeito do tipo ansiolítico. Por outro lado, a administração do antagonista de receptores 5-HT2C SB-242084 promoveu efeito oposto sobre essa mesma resposta. Adicionalmente administração do agonista preferencial de receptores 5-HT2A DOI não foi capaz de promover efeito em nenhuma das doses utilizadas. Nenhum dos tratamentos empregados alterou a resposta de fuga no LTE. O efeito ansiolítico da ativação dos receptores 5-HT2C, bem como o efeito ansiogênico resultante do seu bloqueio, foram confirmados no teste do beber punido de Vogel. Em suma, nossos resultados sugerem que os receptores do tipo 5-HT2C do hipocampo dorsal estão envolvidos na modulação de comportamentos defensivos relacionados ao transtorno de ansiedade generalizada, mas não ao transtorno do pânico. / Studies using intracerebral microinfusion of drugs have been performed to unveil the role of the hippocampus serotonergic system in the modulation of anxiety-related defensive behaviors. For instance, it has been shown that activation of 5-HT1A receptors in the dorsal hippocampus (DH) facilitated inhibitory avoidance acquisition, suggesting an anxiogenic effect, without altering escape expression in rats tested in the elevated T-maze (ETM). This selective effect on inhibitory avoidance response is consistent with the notion that the hippocampus is critically involved in the pathophysiology of generalized anxiety disorder. Besides 5-HT1A receptors, expressive levels of 5-HT2C receptors are also reported in hippocampus. Compelling evidence from animal studies shows that facilitation of 5-HT2C receptor-mediated neurotransmission increases anxiety. In this study we evaluated the involvement the 5-HT2C receptors of the DH in the regulation of defensive behaviors that have been associated with generalized anxiety and panic. Male Wistar rats were tested in the ETM after intra-DH injection of the 5-HT2C receptor agonists MK-212, RO-600175, or the preferential 5-HT2A receptor agonist DOI, or the 5-HT2C receptor antagonist SB242084. For comparative reason, the effect of MK-212, RO-600175 and SB-242084 was also evaluated on another generalized anxiety-associated model, the Vogel conflict test. Our results showed that while intra-DH microinjection of both MK-212 and RO-600175 facilitated inhibitory avoidance acquisition, suggesting an anxiolytic effect, SB-242084 had the opposite effect. Injections of DOI did not affected performance in ETM. None of these drugs affected escape performance in the ETM. The anxiolytic-like effects of the 5-HT2C receptor agonists and anxiogenic-like effect of the SB-242084 were also observed in the Vogel conflict test. Our findings indicate that 5-HT2C receptors in DH are selectively involved in the regulation of defensive behaviors associated with generalized anxiety, but not panic.